NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

The agency identified six cases in Sanofi’s phase 3 program that met Hy’s Law—a rule of thumb for assessing the risk of ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.

Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...